ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,939,114 | -22.5% | 720,842 | -12.4% | 0.00% | -50.0% |
Q2 2023 | $16,704,407 | +76.5% | 822,472 | +58.5% | 0.00% | +100.0% |
Q1 2023 | $9,466,924 | +16.9% | 519,020 | +32.5% | 0.00% | 0.0% |
Q4 2022 | $8,100,563 | -1.0% | 391,710 | +25.2% | 0.00% | -33.3% |
Q3 2022 | $8,185,000 | -15.5% | 312,901 | -18.1% | 0.00% | 0.0% |
Q2 2022 | $9,683,000 | +13.9% | 382,127 | +41.9% | 0.00% | +50.0% |
Q1 2022 | $8,501,000 | -13.6% | 269,351 | +10.8% | 0.00% | – |
Q4 2021 | $9,838,000 | +110.8% | 243,054 | +81.7% | 0.00% | – |
Q3 2021 | $4,666,000 | -22.1% | 133,787 | -38.7% | 0.00% | – |
Q2 2021 | $5,993,000 | +41.9% | 218,254 | +45.1% | 0.00% | – |
Q1 2021 | $4,223,000 | -42.0% | 150,408 | -46.4% | 0.00% | – |
Q4 2020 | $7,278,000 | +96.9% | 280,434 | +30.1% | 0.00% | – |
Q3 2020 | $3,696,000 | +39.4% | 215,627 | +101.2% | 0.00% | – |
Q2 2020 | $2,651,000 | +1340.8% | 107,158 | +428.6% | 0.00% | – |
Q3 2019 | $184,000 | -22.7% | 20,271 | -32.1% | 0.00% | – |
Q2 2019 | $238,000 | – | 29,842 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |